HCID 89758788, compound → HCID 71715656, compound
Reaction equation
[S:1](=[O:31])(=[O:30])([O:3][CH2:4][C@H:5]1[CH2:9][C@@H:8]([NH:10][C:11]2[N:16]3[N:17]=[C:18]([C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)[CH:19]=[C:15]3[N:14]=[C:13](Cl)[C:12]=2[CH3:27])[C@H:7]([OH:28])[C@@H:6]1[OH:29])[NH2:2]>[Pd].O1CCCC1>[S:1](=[O:31])(=[O:30])([O:3][CH2:4][C@H:5]1[CH2:9][C@@H:8]([NH:10][C:11]2[N:16]3[N:17]=[C:18]([C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)[CH:19]=[C:15]3[N:14]=[CH:13][C:12]=2[CH3:27])[C@H:7]([OH:28])[C@@H:6]1[OH:29])[NH2:2]Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A pressure bottle is charged with (rac)-{(1R,2R,3S,4R)-4-[(5-chloro-6-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-2,3-dihydroxycyclopentyl}methyl rel-sulfamate (111 mg, 0.237 mmol), tetrahydrofuran (1.4 mL) and Pd [10% on carbon/50% water wet; Degussa type) 76 mg, 0.036 mmol)]. The reaction is stirred at room temperature under an atmosphere of hydrogen (30 psi) for 18 hr. The reaction mixture is filtered through celite and concentrated in vacuo. The crude material is purified by preparative HPLC to provide (rac)-{(1R,2R,3S,4R)-2,3-dihydroxy-4-[(6-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl}methyl rel-sulfamate (15 mg, yield 13%). LCMS: (FA) M+1 434; 1H NMR (400 MHz, MeOD) δ 8.05-7.98 (m, 2H), 7.94 (s, 1H), 7.43 (t, J=7.4 Hz, 2H), 7.36 (t, J=7.3 Hz, 1H), 6.69 (s, 1H), 4.20 (t, J=7.8 Hz, 2H), 4.03-3.94 (m, 2H), 2.64 (s, 1H), 2.54-2.31 (m, 5H), 1.64-1.51 (m, 1H).
Workup
- filtrationThe reaction mixture is filtered through celite and
- concentrationconcentrated in vacuo
- customThe crude material is purified by preparative HPLC
Sources & evidence
- ORD record
- ord-1d3e6bd78eee439382550b7035f22c68
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09290500B2
Reaction notes
Loading…